{"transactions":[{"id":2223198,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-06-23T16:19:07.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 21, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":1.17,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-018038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000112760222018038/form4.xml","form_type":"4"}},{"id":2223197,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:15:36.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-22-038863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919122038863/doc4.xml","form_type":"4"}},{"id":2434031,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T16:30:26.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":657,"price":31.58,"value":20748.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022."}],"balance_after":1118,"source":{"system":"sec-edgar","filing":"0001209191-22-003503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919122003503/doc4.xml","form_type":"4"}},{"id":2549675,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:55:15.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":461,"price":44.99,"value":20740.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount has been adjusted to reflect 6,641 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust."}],"balance_after":461,"source":{"system":"sec-edgar","filing":"0001209191-21-059522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121059522/doc4.xml","form_type":"4"}},{"id":2639815,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T16:30:44.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":522,"price":39.72,"value":20733.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 2, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount has been adjusted to reflect 92,817 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust."}],"balance_after":6641,"source":{"system":"sec-edgar","filing":"0001209191-21-045807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121045807/doc4.xml","form_type":"4"}},{"id":2661639,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-06-21T16:26:13.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":10.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-21-020399","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000112760221020399/form4.xml","form_type":"4"}},{"id":2664317,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T16:15:41.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":37.66,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-21-041423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121041423/doc4.xml","form_type":"4"}},{"id":2670557,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T17:16:49.000Z","date":"2021-06-14","kind":"other","acquired":true,"shares":22598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. (\"Cobro Ventures\") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1874805,"source":{"system":"sec-edgar","filing":"0001209191-21-040278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121040278/doc4.xml","form_type":"4"}},{"id":2670556,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T17:16:49.000Z","date":"2021-06-14","kind":"other","acquired":true,"shares":92817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the receipt of shares by the Reporting Person pursuant to pro rata distributions-in-kind, without consideration, of shares of the company's common stock effected on June 14, 2021 by Cobro Ventures Opportunity Fund, L.P. (\"Cobro Ventures\") to the partners of Cobro Ventures and by its general partner, Cobro Ventures Fund GP, LLC. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended."}],"balance_after":98936,"source":{"system":"sec-edgar","filing":"0001209191-21-040278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121040278/doc4.xml","form_type":"4"}},{"id":2755987,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-06T16:30:24.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":553,"price":37.51,"value":20743.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021."}],"balance_after":6119,"source":{"system":"sec-edgar","filing":"0001209191-21-025661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121025661/doc4.xml","form_type":"4"}},{"id":2846663,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T16:15:35.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents underlying unexercised stock options that were granted on July 13, 2016. The terms of the original grant provide that 12.5% of this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each such date."}],"balance_after":3209,"derivative":{"exercise_price":2.11,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":536},"source":{"system":"sec-edgar","filing":"0001209191-21-012339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121012339/doc4.xml","form_type":"4"}},{"id":2846662,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T16:15:35.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":536,"price":2.11,"value":1130.96,"ownership":{"direct":true},"balance_after":5566,"source":{"system":"sec-edgar","filing":"0001209191-21-012339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000120919121012339/doc4.xml","form_type":"4"}},{"id":3011867,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":20952403,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Cobro Ventures Opportunity Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cobro Ventures Opportunity Fund, L.P. (\"Cobro Ventures\"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2484425},"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011866,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":12500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1482183},"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011865,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":237149},"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011864,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"purchase","acquired":true,"shares":5030,"price":19,"value":95570.0,"ownership":{"direct":true},"balance_after":5030,"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011863,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":2484425,"ownership":{"direct":false,"nature":"By Cobro Ventures Opportunity Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Cobro Ventures Opportunity Fund, L.P. (\"Cobro Ventures\"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein."}],"balance_after":2484425,"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011862,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":1482183,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1852207,"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3011861,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:28:03.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":237149,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":370024,"source":{"system":"sec-edgar","filing":"0000899243-20-027697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027697/doc4.xml","form_type":"4"}},{"id":3013753,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T21:00:22.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":17786,"derivative":{"exercise_price":19,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0000899243-20-027447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027447/doc4.xml","form_type":"4"}},{"id":3013752,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T21:00:22.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":725002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12.5% of this option shall vest and become exercisable on April 1, 2021, with the remainder vesting in 14 equal quarterly installments thereafter."}],"balance_after":725002,"derivative":{"exercise_price":19,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":725002},"source":{"system":"sec-edgar","filing":"0000899243-20-027447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320027447/doc4.xml","form_type":"4"}},{"id":3112131,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2020-06-12T07:19:38.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":18.63,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-20-019478","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000112760220019478/form4.xml","form_type":"4"}},{"id":3295096,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":20778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":20778},"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295095,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":20778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":20778},"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295094,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":21827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in equal monthly installments over a two year period commencing on February 1, 2019, and will be fully vested and exercisable on January 1, 2021."}],"balance_after":32918,"derivative":{"exercise_price":3.37,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":21827},"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295093,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":16691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022."}],"balance_after":50072,"derivative":{"exercise_price":0.61,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":16691},"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295092,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":8042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2017, and will be fully vested and exercisable on January 1, 2021."}],"balance_after":12063,"derivative":{"exercise_price":0.61,"expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":8042},"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295091,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":20778,"price":3.37,"value":70021.86,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"balance_after":605820,"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295090,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":20778,"price":3.37,"value":70021.86,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"balance_after":585042,"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295089,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":21827,"price":3.37,"value":73556.99,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"balance_after":564264,"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295088,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":16691,"price":0.61,"value":10181.51,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"balance_after":542437,"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3295087,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-03T16:05:48.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":8042,"price":0.61,"value":4905.62,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"balance_after":525746,"source":{"system":"sec-edgar","filing":"0000899243-20-002536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924320002536/doc4.xml","form_type":"4"}},{"id":3351128,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-12-05T15:00:42.000Z","date":"2019-12-03","kind":"grant","acquired":true,"shares":20778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":20778,"derivative":{"exercise_price":3.37,"expiration_date":"2029-04-16","underlying":"Common Stock","underlying_shares":20778},"source":{"system":"sec-edgar","filing":"0000899243-19-028544","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319028544/doc4.xml","form_type":"4"}},{"id":3396153,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-10-08T20:31:49.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":163388,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0000899243-19-025352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319025352/doc4.xml","form_type":"4"}},{"id":3396152,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-10-08T20:31:49.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":543219,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":80650},"source":{"system":"sec-edgar","filing":"0000899243-19-025352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319025352/doc4.xml","form_type":"4"}},{"id":3396151,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-10-08T20:31:49.000Z","date":"2019-10-07","kind":"exercise","acquired":false,"shares":2292235,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":340321},"source":{"system":"sec-edgar","filing":"0000899243-19-025352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319025352/doc4.xml","form_type":"4"}},{"id":3396150,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-08T20:31:49.000Z","date":"2019-10-07","kind":"purchase","acquired":true,"shares":17857,"price":14,"value":249998.0,"ownership":{"direct":true},"balance_after":17857,"source":{"system":"sec-edgar","filing":"0000899243-19-025352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319025352/doc4.xml","form_type":"4"}},{"id":3396149,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":125923,"kind":"person","name":"COHEN MARC A","position":1,"cik":"0001132945","reported_name":"COHEN MARC A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-08T20:31:49.000Z","date":"2019-10-07","kind":"exercise","acquired":true,"shares":445229,"ownership":{"direct":false,"nature":"The Marc Andrew Cohen Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a 0.148467077-for-one basis."}],"balance_after":517704,"source":{"system":"sec-edgar","filing":"0000899243-19-025352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132945/000089924319025352/doc4.xml","form_type":"4"}}]}